N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• N6-methyladenosine (m6A) is a prevalent RNA modification influencing gene expression.
• m6A RNA modification plays a critical role in the development and progression of colorectal cancer (CRC).
• The interplay between m6A and non-coding RNAs (ncRNAs) in CRC is an emerging area of research.

Purpose of the Study:

• To review the multifaceted roles of m6A modification in colorectal cancer.
• To systematically elaborate on the functional and mechanistic interactions between m6A modification and regulatory ncRNAs in CRC.
• To discuss the potential clinical applications of targeting m6A pathways in CRC treatment.

Main Methods:

• Literature review of studies on m6A modification in CRC.
• Analysis of the regulatory mechanisms involving m6A, mRNAs, and ncRNAs in CRC.
• Synthesis of current knowledge on the clinical relevance of m6A in CRC.

Main Results:

• m6A modification influences gene expression in CRC through both mRNAs and ncRNAs.
• Specific ncRNAs are shown to interact with m6A machinery, affecting CRC progression.
• Evidence suggests m6A regulators are potential biomarkers and therapeutic targets for CRC.

Conclusions:

• m6A RNA modification is a key regulator in colorectal cancer.
• Understanding the m6A-ncRNA axis provides insights into CRC pathogenesis.
• Targeting m6A modifications holds promise for future CRC diagnostics and therapeutics.